198 related articles for article (PubMed ID: 21900081)
21. Inhibitory kappa-B kinase-β inhibition prevents adaptive left ventricular hypertrophy.
Andersen NM; Tang R; Li L; Javan H; Zhang XQ; Selzman CH
J Surg Res; 2012 Nov; 178(1):105-9. PubMed ID: 22464396
[TBL] [Abstract][Full Text] [Related]
22. The ATP-binding cassette transporter ABCG2 protects against pressure overload-induced cardiac hypertrophy and heart failure by promoting angiogenesis and antioxidant response.
Higashikuni Y; Sainz J; Nakamura K; Takaoka M; Enomoto S; Iwata H; Tanaka K; Sahara M; Hirata Y; Nagai R; Sata M
Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):654-61. PubMed ID: 22116099
[TBL] [Abstract][Full Text] [Related]
23. Syndecan-4 deficiency accelerates the transition from compensated hypertrophy to heart failure following pressure overload.
Li G; Xie J; Chen J; Li R; Wu H; Zhang X; Chen Q; Gu R; Xu B
Cardiovasc Pathol; 2017; 28():74-79. PubMed ID: 28395201
[TBL] [Abstract][Full Text] [Related]
24. Estrogen inhibits mast cell chymase release to prevent pressure overload-induced adverse cardiac remodeling.
Li J; Jubair S; Janicki JS
Hypertension; 2015 Feb; 65(2):328-34. PubMed ID: 25403608
[TBL] [Abstract][Full Text] [Related]
25. Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload.
Kuster GM; Kotlyar E; Rude MK; Siwik DA; Liao R; Colucci WS; Sam F
Circulation; 2005 Feb; 111(4):420-7. PubMed ID: 15687129
[TBL] [Abstract][Full Text] [Related]
26. Myocardial Galectin-3 Expression Is Associated with Remodeling of the Pressure-Overloaded Heart and May Delay the Hypertrophic Response without Affecting Survival, Dysfunction, and Cardiac Fibrosis.
Frunza O; Russo I; Saxena A; Shinde AV; Humeres C; Hanif W; Rai V; Su Y; Frangogiannis NG
Am J Pathol; 2016 May; 186(5):1114-27. PubMed ID: 26948424
[TBL] [Abstract][Full Text] [Related]
27. Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure.
Szabó Z; Magga J; Alakoski T; Ulvila J; Piuhola J; Vainio L; Kivirikko KI; Vuolteenaho O; Ruskoaho H; Lipson KE; Signore P; Kerkelä R
Hypertension; 2014 Jun; 63(6):1235-40. PubMed ID: 24688123
[TBL] [Abstract][Full Text] [Related]
28. TIMP-2 mutant decreases MMP-2 activity and augments pressure overload induced LV dysfunction and heart failure.
Givvimani S; Kundu S; Narayanan N; Armaghan F; Qipshidze N; Pushpakumar S; Vacek TP; Tyagi SC
Arch Physiol Biochem; 2013 May; 119(2):65-74. PubMed ID: 23398532
[TBL] [Abstract][Full Text] [Related]
29. Regression of cardiac hypertrophy by granulocyte colony-stimulating factor-stimulated interleukin-1β synthesis.
Szardien S; Nef HM; Voss S; Troidl C; Liebetrau C; Hoffmann J; Rauch M; Mayer K; Kimmich K; Rolf A; Rixe J; Troidl K; Kojonazarov B; Schermuly RT; Kostin S; Elsässer A; Hamm CW; Möllmann H
Eur Heart J; 2012 Mar; 33(5):595-605. PubMed ID: 22106340
[TBL] [Abstract][Full Text] [Related]
30. The vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a murine model of pressure overload.
Meems LM; Cannon MV; Mahmud H; Voors AA; van Gilst WH; Silljé HH; Ruifrok WP; de Boer RA
J Steroid Biochem Mol Biol; 2012 Nov; 132(3-5):282-9. PubMed ID: 22800987
[TBL] [Abstract][Full Text] [Related]
31. Recombinant Human ADAMTS13 Treatment Improves Myocardial Remodeling and Functionality After Pressure Overload Injury in Mice.
Witsch T; Martinod K; Sorvillo N; Portier I; De Meyer SF; Wagner DD
J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29367415
[TBL] [Abstract][Full Text] [Related]
32. T₁ mapping detects pharmacological retardation of diffuse cardiac fibrosis in mouse pressure-overload hypertrophy.
Stuckey DJ; McSweeney SJ; Thin MZ; Habib J; Price AN; Fiedler LR; Gsell W; Prasad SK; Schneider MD
Circ Cardiovasc Imaging; 2014 Mar; 7(2):240-9. PubMed ID: 24425501
[TBL] [Abstract][Full Text] [Related]
33. Double-stranded RNA-dependent protein kinase deficiency protects the heart from systolic overload-induced congestive heart failure.
Wang H; Xu X; Fassett J; Kwak D; Liu X; Hu X; Falls TJ; Bell JC; Li H; Bitterman P; Bache RJ; Chen Y
Circulation; 2014 Apr; 129(13):1397-406. PubMed ID: 24463368
[TBL] [Abstract][Full Text] [Related]
34. Relationships between early inflammatory response to bleomycin and sensitivity to lung fibrosis: a role for dipeptidyl-peptidase I and tissue inhibitor of metalloproteinase-3?
Pottier N; Chupin C; Defamie V; Cardinaud B; Sutherland R; Rios G; Gauthier F; Wolters PJ; Berthiaume Y; Barbry P; Mari B
Am J Respir Crit Care Med; 2007 Dec; 176(11):1098-107. PubMed ID: 17673693
[TBL] [Abstract][Full Text] [Related]
35. Candesartan antagonizes pressure overload-evoked cardiac remodeling through Smad7 gene-dependent MMP-9 suppression.
Yu H; Zhao G; Li H; Liu X; Wang S
Gene; 2012 Apr; 497(2):301-6. PubMed ID: 22326534
[TBL] [Abstract][Full Text] [Related]
36. In vivo cardiac role of migfilin during experimental pressure overload.
Haubner BJ; Moik D; Schuetz T; Reiner MF; Voelkl JG; Streil K; Bader K; Zhao L; Scheu C; Mair J; Pachinger O; Metzler B
Cardiovasc Res; 2015 Jun; 106(3):398-407. PubMed ID: 25852081
[TBL] [Abstract][Full Text] [Related]
37. Activation of adenosine A1 receptor attenuates tumor necrosis factor-α induced hypertrophy of cardiomyocytes.
Liao Y; Lin L; Lu D; Fu Y; Bin J; Xu D; Kitakaze M
Biomed Pharmacother; 2011 Oct; 65(7):491-5. PubMed ID: 21993001
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-33 Controls Adaptive Fibrotic Response in the Remodeling Heart by Preserving Lipid Raft Cholesterol.
Nishiga M; Horie T; Kuwabara Y; Nagao K; Baba O; Nakao T; Nishino T; Hakuno D; Nakashima Y; Nishi H; Nakazeki F; Ide Y; Koyama S; Kimura M; Hanada R; Nakamura T; Inada T; Hasegawa K; Conway SJ; Kita T; Kimura T; Ono K
Circ Res; 2017 Mar; 120(5):835-847. PubMed ID: 27920122
[TBL] [Abstract][Full Text] [Related]
39. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.
Shimano M; Ouchi N; Shibata R; Ohashi K; Pimentel DR; Murohara T; Walsh K
J Mol Cell Cardiol; 2010 Aug; 49(2):210-20. PubMed ID: 20206634
[TBL] [Abstract][Full Text] [Related]
40. Olmesartan attenuates cardiac remodeling through DLL4/Notch1 pathway activation in pressure overload mice.
You J; Wu J; Jiang G; Guo J; Wang S; Li L; Ge J; Zou Y
J Cardiovasc Pharmacol; 2013 Feb; 61(2):142-51. PubMed ID: 23188126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]